A potent synthetic cannabinoid caused loss of consciousness in 81% of emergency cases, with seizures in 30% and four deaths
Across 202 emergency presentations in Birmingham involving MDMB-4en-PINACA, the most common features were unconsciousness (81%), agitation (49%), and seizures (30%), disproportionately affecting homeless men.
Quick Facts
What This Study Found
Of 202 presentations involving 163 patients, 81.2% had reduced consciousness, 49% agitation, 30.2% seizures, and four died. Majority male (82.6%), median age 39, 32.2% homeless. In 88.1% of cases other substances were also detected, but 15 single-substance cases showed similar features.
Key Numbers
202 presentations, 163 patients. 81.2% unconscious. 49% agitation. 30.2% seizures. 4 deaths. 32.2% homeless. 82.6% male. 88.1% polydrug.
How They Did This
Retrospective case series from Birmingham UK emergency departments (November 2020 to December 2024) with analytically confirmed MDMB-4en-PINACA exposure via routine toxicological screening.
Why This Research Matters
Synthetic cannabinoids are far more dangerous than plant cannabis but popular in vulnerable populations due to low cost. This documents the severe clinical profile of one of the most prevalent synthetic cannabinoids currently circulating.
The Bigger Picture
While cannabis legalization debates focus on plant products, synthetic cannabinoids remain a deadly and largely unaddressed crisis among society's most vulnerable populations.
What This Study Doesn't Tell Us
Single city. Most cases involved polydrug use. Only patients reaching the ED were captured.
Questions This Raises
- ?Would harm reduction interventions (drug checking, safe consumption sites) reduce synthetic cannabinoid harms in homeless populations?
Trust & Context
- Key Stat:
- 81.2% reduced consciousness; 30.2% seizures; 4 deaths
- Evidence Grade:
- Large case series with analytically confirmed exposures over 4 years, though polydrug use in most cases limits attribution.
- Study Age:
- 2026 publication covering 2020-2024
- Original Title:
- Clinical features and sociodemographic characteristics associated with analytically confirmed exposure to MDMB-4en-PINACA.
- Published In:
- Clinical toxicology (Philadelphia, Pa.), 1-8 (2026)
- Authors:
- Moyns, Emma Jayne, Starbrook, Lauren(2), Pucci, Mark(2)
- Database ID:
- RTHC-08508
Evidence Hierarchy
Describes what happened to one person or a small group.
What do these levels mean? →Frequently Asked Questions
Is this the same as regular cannabis?
No. MDMB-4en-PINACA is a synthetic compound far more potent and dangerous than natural cannabis. It causes seizures, unconsciousness, and death at rates never seen with plant cannabis.
Why is it popular among homeless populations?
Synthetic cannabinoids are cheap and extremely potent, providing a strong effect per dollar.
Read More on RethinkTHC
- 420-sober-survival-guide
- CBT-cannabis-recovery
- THC-purity-potency-label-meaning
- cannabis-relapse-cycle-pattern
- cold-turkey-vs-taper-quit-weed
- dab-concentrate-addiction-withdrawal
- dating-sober-after-quitting-weed
- delta-8-addiction-withdrawal
- edible-addiction-withdrawal-different
- edibles-psychosis-emergency-room
- exercise-quitting-weed-anxiety-brain
- grieving-quitting-weed-loss
- healthiest-way-to-consume-cannabis
- help-someone-quit-weed
- how-cannabis-products-made-concentrates-edibles
- how-to-quit-weed
- journaling-weed-withdrawal
- laced-weed-fentanyl-contaminated-vape
- legal-weed-vs-street-weed-quality-safety
- marijuana-anonymous-SMART-recovery-compare
- meditation-mindfulness-weed-withdrawal
- partner-still-smokes-weed
- partner-still-smokes-weed-quitting
- pink-cloud-sobriety-cannabis
- quit-weed-cold-turkey
- quit-weed-or-cut-back-which-is-better
- quit-weed-regret-went-back
- quitting-dabs-withdrawal
- quitting-edibles-withdrawal
- quitting-weed-20s
- quitting-weed-30s
- quitting-weed-after-years
- quitting-weed-during-crisis-divorce-job-loss
- quitting-weed-exercise
- quitting-weed-grief-loss-coping
- quitting-weed-legal-state
- quitting-weed-success-stories
- quitting-weed-triggers-environment
- relapsed-smoking-weed-what-to-do
- relapsed-weed
- sativa-vs-indica-difference-myth
- should-i-quit-weed
- sober-music-festival-concert-without-weed
- supplements-weed-withdrawal
- telling-friends-quitting-weed
- weed-potency-withdrawal
- weed-relapse-prevention-plan
- weed-relapse-why-it-happens
- weed-ritual-replacement
- weed-ruined-relationships
- weed-social-media-triggers-quit
Cite This Study
https://rethinkthc.com/research/RTHC-08508APA
Moyns, Emma Jayne; Starbrook, Lauren; Pucci, Mark. (2026). Clinical features and sociodemographic characteristics associated with analytically confirmed exposure to MDMB-4en-PINACA.. Clinical toxicology (Philadelphia, Pa.), 1-8. https://doi.org/10.1080/15563650.2025.2608229
MLA
Moyns, Emma Jayne, et al. "Clinical features and sociodemographic characteristics associated with analytically confirmed exposure to MDMB-4en-PINACA.." Clinical toxicology (Philadelphia, 2026. https://doi.org/10.1080/15563650.2025.2608229
RethinkTHC
RethinkTHC Research Database. "Clinical features and sociodemographic characteristics assoc..." RTHC-08508. Retrieved from https://rethinkthc.com/research/moyns-2026-clinical-features-and-sociodemographic
Access the Original Study
Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.
This study breakdown was produced by the RethinkTHC research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.